Logo image of CBNK

CAPITAL BANCORP INC/MD (CBNK) Stock Fundamental Analysis

NASDAQ:CBNK - Nasdaq - US1397371006 - Common Stock - Currency: USD

31.39  +0.33 (+1.06%)

After market: 31.39 0 (0%)

Fundamental Rating

4

Taking everything into account, CBNK scores 4 out of 10 in our fundamental rating. CBNK was compared to 398 industry peers in the Banks industry. The financial health of CBNK is average, but there are quite some concerns on its profitability. CBNK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CBNK was profitable.
In the past year CBNK had a positive cash flow from operations.
In the past 5 years CBNK has always been profitable.
Each year in the past 5 years CBNK had a positive operating cash flow.
CBNK Yearly Net Income VS EBIT VS OCF VS FCFCBNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

CBNK has a Return On Assets of 0.97%. This is in the better half of the industry: CBNK outperforms 63.82% of its industry peers.
CBNK has a Return On Equity (8.72%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.97%
ROE 8.72%
ROIC N/A
ROA(3y)1.52%
ROA(5y)1.57%
ROE(3y)13.82%
ROE(5y)15.57%
ROIC(3y)N/A
ROIC(5y)N/A
CBNK Yearly ROA, ROE, ROICCBNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CBNK has a worse Profit Margin (16.64%) than 71.86% of its industry peers.
CBNK's Profit Margin has declined in the last couple of years.
CBNK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 16.64%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.38%
PM growth 5Y-1.96%
GM growth 3YN/A
GM growth 5YN/A
CBNK Yearly Profit, Operating, Gross MarginsCBNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

CBNK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBNK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CBNK has more shares outstanding
Compared to 1 year ago, CBNK has an improved debt to assets ratio.
CBNK Yearly Shares OutstandingCBNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CBNK Yearly Total Debt VS Total AssetsCBNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CBNK has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.37, CBNK belongs to the top of the industry, outperforming 84.42% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that CBNK is not too dependend on debt financing.
The Debt to Equity ratio of CBNK (0.03) is better than 84.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.37
Altman-Z N/A
ROIC/WACCN/A
WACC15.59%
CBNK Yearly LT Debt VS Equity VS FCFCBNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNK Yearly Current Assets VS Current LiabilitesCBNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

CBNK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.53%.
The Earnings Per Share has been growing by 16.89% on average over the past years. This is quite good.
Looking at the last year, CBNK shows a quite strong growth in Revenue. The Revenue has grown by 11.80% in the last year.
The Revenue has been growing by 15.14% on average over the past years. This is quite good.
EPS 1Y (TTM)3.53%
EPS 3Y-2.29%
EPS 5Y16.89%
EPS Q2Q%41.54%
Revenue 1Y (TTM)11.8%
Revenue growth 3Y3.62%
Revenue growth 5Y15.14%
Sales Q2Q%37.76%

3.2 Future

Based on estimates for the next years, CBNK will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.00% on average per year.
The Revenue is expected to grow by 18.60% on average over the next years. This is quite good.
EPS Next Y23.44%
EPS Next 2Y16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.9%
Revenue Next 2Y18.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CBNK Yearly Revenue VS EstimatesCBNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CBNK Yearly EPS VS EstimatesCBNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

CBNK is valuated reasonably with a Price/Earnings ratio of 11.89.
CBNK's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CBNK to the average of the S&P500 Index (28.22), we can say CBNK is valued rather cheaply.
CBNK is valuated reasonably with a Price/Forward Earnings ratio of 9.63.
CBNK's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.86. CBNK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.89
Fwd PE 9.63
CBNK Price Earnings VS Forward Price EarningsCBNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CBNK's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CBNK is more expensive than 65.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.96
EV/EBITDA N/A
CBNK Per share dataCBNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CBNK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBNK's earnings are expected to grow with 16.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)0.7
EPS Next 2Y16%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

CBNK has a Yearly Dividend Yield of 1.34%.
Compared to an average industry Dividend Yield of 3.52, CBNK is paying slightly less dividend.
With a Dividend Yield of 1.34, CBNK pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

CBNK has been paying a dividend for over 5 years, so it has already some track record.
CBNK has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
CBNK Yearly Dividends per shareCBNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

CBNK pays out 17.03% of its income as dividend. This is a sustainable payout ratio.
DP17.03%
EPS Next 2Y16%
EPS Next 3YN/A
CBNK Yearly Income VS Free CF VS DividendCBNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M
CBNK Dividend Payout.CBNK Dividend Payout, showing the Payout Ratio.CBNK Dividend Payout.PayoutRetained Earnings

CAPITAL BANCORP INC/MD

NASDAQ:CBNK (5/2/2025, 8:00:02 PM)

After market: 31.39 0 (0%)

31.39

+0.33 (+1.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-17 2025-04-17/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners36.98%
Inst Owner Change-0.3%
Ins Owners26.26%
Ins Owner Change2.4%
Market Cap522.96M
Analysts84
Price Target34.94 (11.31%)
Short Float %1.07%
Short Ratio2.5
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP17.03%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-10 2025-02-10 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.05%
Min EPS beat(2)-5.19%
Max EPS beat(2)39.3%
EPS beat(4)1
Avg EPS beat(4)5.69%
Min EPS beat(4)-8.57%
Max EPS beat(4)39.3%
EPS beat(8)4
Avg EPS beat(8)6.5%
EPS beat(12)7
Avg EPS beat(12)7.07%
EPS beat(16)11
Avg EPS beat(16)10.44%
Revenue beat(2)1
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)0.66%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)0.66%
Revenue beat(8)1
Avg Revenue beat(8)-2.1%
Revenue beat(12)1
Avg Revenue beat(12)-2.92%
Revenue beat(16)3
Avg Revenue beat(16)-1.74%
PT rev (1m)-4.86%
PT rev (3m)7.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.86%
EPS NY rev (1m)-1.31%
EPS NY rev (3m)2.82%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)1.73%
Revenue NY rev (1m)-1.84%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE 11.89
Fwd PE 9.63
P/S 2.81
P/FCF 15.96
P/OCF 14.97
P/B 1.47
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)2.64
EY8.41%
EPS(NY)3.26
Fwd EY10.38%
FCF(TTM)1.97
FCFY6.27%
OCF(TTM)2.1
OCFY6.68%
SpS11.17
BVpS21.32
TBVpS19.1
PEG (NY)0.51
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 0.97%
ROE 8.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 16.64%
GM N/A
FCFM 17.6%
ROA(3y)1.52%
ROA(5y)1.57%
ROE(3y)13.82%
ROE(5y)15.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.38%
PM growth 5Y-1.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.37
Debt/EBITDA N/A
Cap/Depr 215.92%
Cap/Sales 1.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 105.8%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC15.59%
ROIC/WACCN/A
Cap/Depr(3y)427.12%
Cap/Depr(5y)263.77%
Cap/Sales(3y)1.13%
Cap/Sales(5y)0.72%
Profit Quality(3y)117.04%
Profit Quality(5y)140.31%
High Growth Momentum
Growth
EPS 1Y (TTM)3.53%
EPS 3Y-2.29%
EPS 5Y16.89%
EPS Q2Q%41.54%
EPS Next Y23.44%
EPS Next 2Y16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.8%
Revenue growth 3Y3.62%
Revenue growth 5Y15.14%
Sales Q2Q%37.76%
Revenue Next Year29.9%
Revenue Next 2Y18.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.6%
FCF growth 3Y-37.17%
FCF growth 5YN/A
OCF growth 1Y-26.34%
OCF growth 3Y-35.82%
OCF growth 5YN/A